<DOC>
<DOCNO>EP-0613503</DOCNO> 
<TEXT>
<INVENTION-TITLE>
METHOD FOR DETERMINING THE QUANTITY OF A DNA FRAGMENT OF INTEREST BY ENZYMATIC AMPLIFICATION OF DNA
</INVENTION-TITLE>
<CLASSIFICATIONS>C12Q168	C12Q168	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C12Q	C12Q	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C12Q1	C12Q1	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
<APPLICANT-NAME>
INST NAT SANTE RECH MED
</APPLICANT-NAME>
<APPLICANT-NAME>
PASTEUR INSTITUT
</APPLICANT-NAME>
<APPLICANT-NAME>
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
</APPLICANT-NAME>
<APPLICANT-NAME>
INSTITUT PASTEUR
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
COCHET MADELEINE
</INVENTOR-NAME>
<INVENTOR-NAME>
DARCHE SYLVIE
</INVENTOR-NAME>
<INVENTOR-NAME>
KOURILSKY PHILIPPE
</INVENTOR-NAME>
<INVENTOR-NAME>
PANNETIER CHRISTOPHE
</INVENTOR-NAME>
<INVENTOR-NAME>
COCHET, MADELEINE
</INVENTOR-NAME>
<INVENTOR-NAME>
DARCHE, SYLVIE
</INVENTOR-NAME>
<INVENTOR-NAME>
KOURILSKY, PHILIPPE
</INVENTOR-NAME>
<INVENTOR-NAME>
PANNETIER, CHRISTOPHE
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Process for determining the quantity of a DNA 
fragment of interest in a sample to be analysed by a 

method of enzymatic amplification in vitro of the said 
fragment, characterized in that: 


1) a standard DNA fragment which differs from the DNA 
fragment of interest but can be amplified with the same 

oligonucleotide primers is added to the sample to be 
analysed containing the DNA fragment of interest, the 

standard DNA fragment and the fragment of interest 
differing in sequence and/or in size by not more than 

approximately 10%, and preferably by not more than 
5 nucleotides per strand, 
2) the DNA fragment of interest and the standard fragment 
are coamplified with the same oligonucleotide primers, 

preferably to saturation of the amplification of the DNA 
fragment of interest, 
3) to the reaction medium obtained in step 2), there are 
added: 


either two types of labelled oligonucleotide probes 
which are each specific for the DNA fragment of 

interest and the standard fragment, respectively, 
and different from the amplification oligonucleotide 

primers of step 2), 
or one or more labelled oligonucleotide primer(s), 
specific for the DNA fragment of interest and the 

standard fragment and different from the said oligonucleotide 
primers of step 2), and one or more 

additional amplification cycle(s) with the said 
labelled oligonucleotide primer(s) is/are performed, 

so that, during a cycle, after denaturation of the  
 

DNA, the said labelled oligonucleotide primer(s) 
hybridize(s) with the said fragments at a suitable 

site in order that an elongation with the DNA 
polymerase generates labelled DNA fragments of 

different sizes and/or sequences and/or with 
different labels according to whether they originate 

from the DNA fragment of interest or the standard 
fragment, respectively, and then 
4) the initial quantity of DNA fragment of interest is 
determined as being the product of the initial quantity 

of standard DNA fragment and the ratio of the quantity of 
amplified DNA fragment of interest to the quantity of 

amplified standard DNA fragment, which ratio is identical 
to that of the quantities of the labelled DNA fragments 

originating from the amplified DNA fragment of interest 
and the amplified standard fragment, respectively, 

obtained in step 3). 
Process according to Claim 1, characterized in 
that the standard DNA fragment and the DNA fragment of 

interest differ in at least one site which can be identified 
by some appropriate means. 
Process according to Claim 1 or 2, characterized 
in that the sizes of the DNA fragment of interest and the 

standard fragment differ by at least 1 and by at most 10% 
of nucleotides or by 1 to 5 nucleotides per strand. 
Process for determining the quantity of a DNA 
fragment of interest by a method 
of enzymatic amplification 
in vitro of DNA according to one of Claims 1 to 3, 

characterized in that, in step 3), a third labelled 
oligonucleotide primer is added to the reaction medium 

obtained in step 2), the primer being common to the DNA 
fragment of interest and the standard fragment, and one 

or more additional amplification cycle(s) is/are performed 
with the said third primer, so that, during a 

cycle, after denaturation of the DNA, the said third 
primer hybridizes specifically with the said fragments at 

a suitable site in order that an elongation with the DNA 
polymerase generates two types of labelled DNA fragments 

of different sizes according to whether they originate  
 

from the DNA fragment of interest or the standard 
fragment, respectively, and each containing only a 

portion of the latter fragments, respectively. 
Process according to one of Claims 1 to 4, 
characterized in that the standard DNA fragment corresponds 

to the DNA fragment of interest in which one or 
more deletion(s), mutation(s) and/or addition(s) of 

nucleotides has/have been performed. 
Process according to either of Claims 4 and 5, 
characterized in that the standard DNA fragment corresponds 

to the DNA fragment of interest in which a 
deletion, mutation or addition at one site of 1 to 5 

nucleotides, and preferably 3 to 4, has been performed, 
and in that the said third primer is an oligonucleotide 

complementary to a sequence located upstream of the said 
deletion, mutation or addition. 
Process for determining the quantity of a DNA of 
interest according to one of Claims 1 to 6, characterized 

in that: 

a) the standard DNA fragment and the fragment of 
interest have the same size and differ in sequence 

by a restriction site for a particular endonuclease, 
or any other site of cleavage which can be produced 

by any other means, and 
b) in step 3), a third labelled oligonucleotide primer 
is added to the reaction medium obtained in step 2), 

the primer being common to the DNA fragment of 
interest and the standard fragment, and one or more 

additional amplification cycle(s) is/are performed 
with the said third primer, so that, during a cycle, 

after denaturation of the DNA, the said third primer 
hybridizes specifically with the said fragments at 

a suitable site in order that an elongation with the 
DNA polymerase generates two types of labelled DNA 

fragments which differ according to whether they 
originate from the DNA fragment of interest or the 

standard fragment, respectively, in that one of the 
said fragments still contains the said restriction 

site, and  
 
c) before step 4), a digestion of the amplification 
products of step 3) is performed, using the said 

endonuclease or any other means of cleavage 
corresponding to the cleavage site, so as to 

generate fragments of different sizes according to 
whether they originate from the DNA fragment of 

interest or the standard fragment. 
Process according to one of Claims 1 to 7, 
characterized in that the determination of step 4) is 

done by 

separating the labelled DNA fragments originating 
from the amplified DNA fragment of interest and the 

amplified standard fragment according to their size 
by gel electrophoresis, and then by 
detecting the intensities of the signals corresponding 
to the label of the said respective primer(s) 

for the labelled DNA fragments originating from the 
DNA fragment of interest and the standard fragment, 

respectively. 
Method according to one of Claims 1 to 7, characterized 
in that the labelled amplified DNA fragments 

originating from the amplified DNA fragment of interest 
and the amplified standard fragment are separated according 

to their size, using a device for gel electrophoresis 
with DNA sequencing. 
Process according to one of the preceding claims 
for multiparametric analysis, enabling several DNA 

fragments of interest to be assayed and quantified in the 
same sample under analysis, characterized in that: 


to the sample to be analysed containing the said DNA 
fragments of interest, an equal number of standard 

DNA fragments are added, the standard DNA fragments 
being different for each of the DNA fragments of 

interest, and 
the standard DNAs and the labelled oligonucleotides 
of step 3) are chosen in such a way as to generate 

fragments of different sizes during step 3). 
Process for determining the quantity of a DNA 
fragment of interest according to one of Claims 1 to 5,  

 
by a method of enzymatic amplification in vitro, characterized 

in that, in step 3), two oligonucleotide probes 
or primers different from the amplification primers of 

step 2), specific for the DNA fragment of interest and 
the standard fragment, respectively, and labelled with 

different labels, are added to reaction medium obtained 
in step 2); one or more additional amplification cycle(s) 

is/are then performed, if appropriate, with the said two 
labelled oligonucleotide primers, so that, during a 

cycle, after denaturation of the DNA and elongation with 
a DNA polymerase, the said two labelled oligonucleotides 

generate two types of DNA fragments, labelled with different 
labels according to whether they originate from 

DNA of interest or standard DNA. 
Process according to Claim 11, characterized in 
that: 


a) in step 2), the amplification primers are chemically 
modified so that can they be linked to a solid 

phase, and 
b) after step 3), the amplification products are linked 
to the solid phase via the said modified primers, 

and the solid phase is then washed so as to remove 
the excess unreacted labelled primers of step 3). 
Process according to Claim 11 or 12, characterized 
in that, if the labelled DNA fragment of interest 

and the labelled standard fragment differ in only one 
site, both oligonucleotide primers of step 3) include 

this site. 
Process according to one of Claims 11 to 13, 
characterized in that the amplification primers of step 

2) are biotinylated, and can react and can bind to 
streptavidin, which is coupled to the solid phase. 
Process according to one of Claims 1 to 14, 
characterized in that the process is repeated several 

times under the same conditions but starting with different 
initial quantities of standard DNA fragments. 
Process according to one of Claims 1 to 15, 
characterized in that the said primer(s) is/are labelled 

with a fluorescent label.  
 
Process according to one of Claims 1 to 16, 
characterized in that the method of enzymatic amplification 

is the PCR method. 
Kit for determining the quantity of a DNA fragment 
of interest by a process according to one of Claims 

1 to 16, characterized in that it contains: 

a standard DNA fragment differing in size and/or in 
sequence by not more than approximately 10%, and 

preferably by not more than 5 nucleotides per 
strand, from the DNA fragment of interest, 
the reactants for carrying out the said method of 
enzymatic amplification in vitro, and in particular 

oligonucleotide primers, 
one or more labelled oligonucleotide probe(s) or 
primer(s), which hybridize(s) specifically with the 

standard DNA fragment and the fragment of interest, 

as appropriate, at a suitable site in order that an 
elongation with the DNA polymerase generates 

labelled DNA fragments of different sizes and/or 
sequences or with different labels according to 

whether they originate from the DNA fragment of 
interest or the standard fragment, respectively. 
</CLAIMS>
</TEXT>
</DOC>
